Identification of ALDH1A2-mediated cardioprotective benefits in myocardial ischaemia-reperfusion injury
Cardiovascular Research · 2026
DOI: 10.1093/cvr/cvaf267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Wei Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institut…. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Myocytes, Cardiac, Aldehyde Dehydrogenase 1 Family, Retinal Dehydrogenase. Die Arbeit nennt 72 Literaturangaben. Gefördert von: National Science Foundation of China, Basic Medicine-Clinical Medicine Transformation Collaborative Fund of Zhongnan Hospital of Wuhan University, Key R&D Program Project of Jiangxi Province.
Abstract (Originalsprache)
Aims
Myocardial ischaemia-reperfusion (MIR) injury is one of the major causes of poor prognosis after revascularization in myocardial infarction. Retinoic acid (RA) signalling is activated after myocardial infarction and participates in cardiac repair after myocardial infarction, but whether it can be applied to target MIR and the specific mechanism underlying its regulation and action in MIR remain unclear. Methods and results We systematically analysed the changes of heart gene transcriptional profile post-MIR and identified cardiomyocyte Aldh1a2 as a central regulator in I/R-induced heart dysfunction. Compared to wild-type controls, Aldh1a2 ablation significantly aggravated heart dysfunction, myocardial damage and fibrosis, while overexpressing ALDH1A2 provided robust protection against heart injury in response to I/R surgery. The in-depth mechanistic investigations indicated that the cardioprotective role of ALDH1A2 is largely dependent on catalyzing RA production. The cardiomyocyte-generated RA inhibited cell death and cardiac fibrosis by binding to RA receptors and regulating the transcription of Bmp7.
Conclusion
In summary, our study indicates that Aldh1a2 is the central RA-producing enzyme mediating the protective effect against MIR injury and the following cardiac remodelling. Potentiating Aldh1a2 transcription and the downstream RA signalling is a potential means of treatment against MIR injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, China; Department of Cardiology…
- Department of Colorectal and Anal Surgery (Clinical Center for Pelvic Floor Surgery), Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
- Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
- Hubei Provincial Engineering Research Center for Model Animals, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China.
- Department of Rehabilitation, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China.
Förderung
- National Science Foundation of China
- Basic Medicine-Clinical Medicine Transformation Collaborative Fund of Zhongnan Hospital of Wuhan University
- Key R&D Program Project of Jiangxi Province
- Ganzhou Science and Technology Plan Project
- the Key R&D Program Project of Jiangxi Province
- Jiangxi Provincial Natural Science Foundation
- the Research Foundation of Jiangxi Province
Zitieren
APA
Li, W., Zhou, S., Liu, J., Luo, L., Zhang, L., Wang, J., Sun, Y., Gan, S., Hu, Y., Yang, H., Wan, R., Zhang, X. J., Cheng, X., Huang, Y., She, Z. G., & Li, H. (2026). Identification of ALDH1A2-mediated cardioprotective benefits in myocardial ischaemia-reperfusion injury. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf267
Vancouver
Li W, Zhou S, Liu J, Luo L, Zhang L, Wang J, et al. Identification of ALDH1A2-mediated cardioprotective benefits in myocardial ischaemia-reperfusion injury. Cardiovascular Research. 2026. doi:10.1093/cvr/cvaf267
BibTeX
@article{Li2026,
author = {Li, Wei and Zhou, Siyi and Liu, Jiayi and Luo, Lei and Zhang, Long and Wang, Jia and Sun, Yazhou and Gan, Shanyu and Hu, Yufeng and Yang, Hailong and Wan, Rong and Zhang, Xiao-Jing and Cheng, Xu and Huang, Ying and She, Zhi-Gang and Li, Hongliang},
title = {Identification of ALDH1A2-mediated cardioprotective benefits in myocardial ischaemia-reperfusion injury},
journal = {Cardiovascular Research},
year = {2026},
doi = {10.1093/cvr/cvaf267}
}
EUVIMED